跳至主要内容
临床试验/CTRI/2026/02/103392
CTRI/2026/02/103392尚未招募1 期

Randomized controlled clinical trial to evaluate the efficacy of Jalaukavacharana in the management of Vranagranti Keloid

CSMSS Ayurved College Kanchanwadi Chhatrapati Sambhajinagar1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2026年2月26日最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
60
试验地点
1

研究概览

简要总结

Keloids are fibroproliferative dermal lesions resulting from abnormal wound healing and excessive collagen deposition. In Ayurveda, a comparable condition is described as Vranagranthi, caused by vitiation of Doshas and Rakta. Conventional treatments for keloids are associated with high recurrence and adverse effects. Jalaukavacharana (leech therapy), a form of Raktamokshana, is indicated in Rakta-Pitta predominant disorders and abnormal wound healing. Hence, this study aims to evaluate the efficacy of Jalaukavacharana in the management of Vranagranthi (keloid).

The study will be conducted on 60 diagnosed patients of Vranagranthi i.e., Keloid.

Screening of patients for inclusion

Initial Assessment for Patient Selection

Informed written consent

Randomization and group Allocation

Trial group (A) 30 Patients- Jalaukavacharana

Control group (B) 30 Patients- Triamcinolone Acetonide

Follow up for assessment ( For a maximum of 28 days)

Observation & Results will be noted

Statistical analysis

Discussion and Conclusion

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
20.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • The patients of age group between 20 to 60 years irrespective of gender Patients clinically diagnosed with Vranagranti Keloid.

排除标准

  • Infected inflamed or ulcerated keloids Allergy to leech saliva or corticosteroids Bleeding disorders uncontrolled hypertension diabetes or immunocompromised status.

研究者

发起方
CSMSS Ayurved College Kanchanwadi Chhatrapati Sambhajinagar
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Khushboo Rajesh Katariya

CSMSS Ayurved Mahavidyalaya And Rugnalaya

研究点 (1)

Loading locations...

相似试验